• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

hepatocellular carcinoma (HCC) - Articles and news items

regorafenib

Regorafenib increases overall survival in hepatocellular carcinoma study

Industry news / 29 June 2016 / Victoria White, Digital Content Producer

Results from the Phase III RESORCE trial investigating Bayer’s regorafenib in patients with unresectable hepatocellular carcinoma have been announced…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +